BIAF
Price
$2.13
Change
-$0.05 (-2.29%)
Updated
Oct 17 closing price
24 days until earnings call
PXMBF
Price
$3.50
Change
-$0.00 (-0.00%)
Updated
May 16 closing price
Ad is loading...

BIAF vs PXMBF

Header iconBIAF vs PXMBF Comparison
Open Charts BIAF vs PXMBFBanner chart's image
bioAffinity Technologies
Price$2.13
Change-$0.05 (-2.29%)
Volume$39.66K
CapitalizationN/A
PAXMAN AB
Price$3.50
Change-$0.00 (-0.00%)
Volume$600
CapitalizationN/A
View a ticker or compare two or three
BIAF vs PXMBF Comparison Chart
Loading...
BIAF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BIAF vs. PXMBF commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIAF is a Buy and PXMBF is a Hold.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (BIAF: $2.13 vs. PXMBF: $3.50)
Brand notoriety: BIAF and PXMBF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BIAF: 56% vs. PXMBF: 100%
Market capitalization -- BIAF: $23.27M vs. PXMBF: $56.48M
BIAF [@Medical Specialties] is valued at $23.27M. PXMBF’s [@Medical Specialties] market capitalization is $56.48M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIAF’s FA Score shows that 0 FA rating(s) are green whilePXMBF’s FA Score has 0 green FA rating(s).

  • BIAF’s FA Score: 0 green, 5 red.
  • PXMBF’s FA Score: 0 green, 5 red.
According to our system of comparison, PXMBF is a better buy in the long-term than BIAF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIAF’s TA Score shows that 6 TA indicator(s) are bullish.

  • BIAF’s TA Score: 6 bullish, 4 bearish.

Price Growth

BIAF (@Medical Specialties) experienced а +10.36% price change this week, while PXMBF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

BIAF is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PXMBF($56.5M) has a higher market cap than BIAF($23.3M). BIAF YTD gains are higher at: 44.849 vs. PXMBF (25.000). PXMBF has higher annual earnings (EBITDA): 21.8M vs. BIAF (-7.01M). PXMBF has more cash in the bank: 29.1M vs. BIAF (4.51M). BIAF has less debt than PXMBF: BIAF (1.69M) vs PXMBF (16.3M). PXMBF has higher revenues than BIAF: PXMBF (160M) vs BIAF (321K).
BIAFPXMBFBIAF / PXMBF
Capitalization23.3M56.5M41%
EBITDA-7.01M21.8M-32%
Gain YTD44.84925.000179%
P/E RatioN/AN/A-
Revenue321K160M0%
Total Cash4.51M29.1M15%
Total Debt1.69M16.3M10%
TECHNICAL ANALYSIS
Technical Analysis
BIAF
RSI
ODDS (%)
Bearish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Ad is loading...
BIAF
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL232.150.37
+0.16%
Apple
SPY582.350.05
+0.01%
SPDR® S&P 500® ETF Trust
TSLA220.89-0.44
-0.20%
Tesla
BTC.X67399.836000-212.882810
-0.31%
Bitcoin cryptocurrency
GME21.41-0.25
-1.15%
GameStop Corp

BIAF and

Correlation & Price change

A.I.dvisor indicates that over the last year, BIAF has been loosely correlated with HSCS. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if BIAF jumps, then HSCS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIAF
1D Price
Change %
BIAF100%
-2.29%
HSCS - BIAF
35%
Loosely correlated
-10.92%
RDNT - BIAF
26%
Poorly correlated
-2.87%
AORT - BIAF
22%
Poorly correlated
-0.60%
OMIC - BIAF
21%
Poorly correlated
-1.74%
EKSO - BIAF
21%
Poorly correlated
-4.63%
More

PXMBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PXMBF has been loosely correlated with IDTA. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PXMBF jumps, then IDTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PXMBF
1D Price
Change %
PXMBF100%
N/A
IDTA - PXMBF
53%
Loosely correlated
N/A
ANSLF - PXMBF
37%
Loosely correlated
N/A
IOBCF - PXMBF
30%
Poorly correlated
+8.39%
BLOZF - PXMBF
23%
Poorly correlated
+0.94%
BIAF - PXMBF
21%
Poorly correlated
-2.29%
More